Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Mar 1;26(5):1315.
doi: 10.3390/molecules26051315.

Potential Therapeutic Targets of Quercetin, a Plant Flavonol, and Its Role in the Therapy of Various Types of Cancer through the Modulation of Various Cell Signaling Pathways

Affiliations
Review

Potential Therapeutic Targets of Quercetin, a Plant Flavonol, and Its Role in the Therapy of Various Types of Cancer through the Modulation of Various Cell Signaling Pathways

Saleh A Almatroodi et al. Molecules. .

Abstract

Polyphenolic flavonoids are considered natural, non-toxic chemopreventers, which are most commonly derived from plants, fruits, and vegetables. Most of these polyphenolics exhibit remarkable antioxidant, anti-inflammatory, and anticancer properties. Quercetin (Qu) is a chief representative of these polyphenolic compounds, which exhibits excellent antioxidant and anticancer potential, and has attracted the attention of researchers working in the area of cancer biology. Qu can regulate numerous tumor-related activities, such as oxidative stress, angiogenesis, cell cycle, tumor necrosis factor, proliferation, apoptosis, and metastasis. The anticancer properties of Qu mainly occur through the modulation of vascular endothelial growth factor (VEGF), apoptosis, phosphatidyl inositol-3-kinase (P13K)/Akt (proteinase-kinase B)/mTOR (mammalian target of rapamycin), MAPK (mitogen activated protein kinase)/ERK1/2 (extracellular signal-regulated kinase 1/2), and Wnt/β-catenin signaling pathways. The anticancer potential of Qu is documented in numerous in vivo and in vitro studies, involving several animal models and cell lines. Remarkably, this phytochemical possesses toxic activities against cancerous cells only, with limited toxic effects on normal cells. In this review, we present extensive research investigations aimed to discuss the therapeutic potential of Qu in the management of different types of cancers. The anticancer potential of Qu is specifically discussed by focusing its ability to target specific molecular signaling, such as p53, epidermal growth factor receptor (EGFR), VEGF, signal transducer and activator of transcription (STAT), PI3K/Akt, and nuclear factor kappa B (NF-κB) pathways. The anticancer potential of Qu has gained remarkable interest, but the exact mechanism of its action remains unclear. However, this natural compound has great pharmacological potential; it is now believed to be a complementary-or alternative-medicine for the prevention and treatment of different cancers.

Keywords: anticancer activity; bioavailability; cell signaling pathways; natural chemopreventers; polyphenolic flavonoids; quercetin.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Chemical structure of quercetin [43].
Figure 2
Figure 2
Quercetin shows role in the inhibition of cancer through the modulation of cell signaling molecules.
Figure 3
Figure 3
Quercetin has a proven anticancer role in multiple cancers, based on in vivo and in vitro studies.
Figure 4
Figure 4
Anticancer activity of quercetin confirmed through the inhibition of carcinogenesis steps, including initiation, promotion, and progression.

References

    1. Bray F., Ferlay J., Soerjomataram I., Siegel R.L., Torre L.A., Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2018;68:394–424. doi: 10.3322/caac.21492. - DOI - PubMed
    1. World Health Organization Cancer 2020. [(accessed on 5 October 2019)]; Available online: https://www.who.int/news-room/fact-sheets/detail/cancer.
    1. Wu S., Zhu W., Thompson P., Hannun Y.A. Evaluating intrinsic and non-intrinsic cancer risk factors. Nat. Commun. 2018;9:3490. doi: 10.1038/s41467-018-05467-z. - DOI - PMC - PubMed
    1. Ames B.N. Mutagenesis and carcinogenesis: Endogenous and exogenous factors. Environ. Mol. Mutagen. 1989;14:66–77. doi: 10.1002/em.2850140614. - DOI - PubMed
    1. Hussain S., Harris C.C. Molecular epidemiology and carcinogenesis: Endogenous and exogenous carcinogens. Mutat. Res. Mutat. Res. 2000;462:311–322. doi: 10.1016/S1383-5742(00)00015-6. - DOI - PubMed